* IOM says risks of certain drugs become apparent over years * Says FDA should monitor safety through drug 'lifecycle' *...
Reuters | Posted 04.23.2012
* Agency has required 385 postmarket studies since 2008 * New safety information led to changed labels 65 times By Debra...
Richard W. Besdine, M.D. | Posted 03.14.2012
For many older Americans, their relationship with the most important drugs in their medicine cabinets can be described as "Can't live with 'em, can't live without 'em."
Edward F. Blizzard | Posted 05.25.2011
Given the body of evidence and the 30-year old questions about propoxyphene, we have to ask: what took the FDA so long to do right the right thing for American consumers?
Steven K. Galson, MD, MPH | Posted 11.17.2011
Even though our system of pharmaceutical review and approval is regarded as the most effective in the world, there exists an incredible -- and potentially deadly -- loophole: unapproved drugs.
AP | MARILYNN MARCHIONE | Posted 11.17.2011
The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was p...
ProPublica | Jeff Gerth | Posted 05.25.2011
GE Healthcare ignored the advice of its own safety experts to "proactively" restrict use of its imaging drug, Omniscan, after reports in Europe linked...
Reuters | Posted 05.02.2012